journal article·2023-01

ROS-triggered self-disintegrating and pH-responsive astaxanthin nanoparticles for regulating the intestinal barrier and colitis

Xuedi Zhang, Xue Zhao, Zheng Hua, Shanghua Xing, Jiaxuan Li, Siyuan Fei, Mingqian Tan

Biomaterials· Volume 292
Publisher page

Abstract

Smart delivery systems with stimuli-responsive capability are able to improve the bioaccessibility through increasing the solubility, physicochemical stability and biocompatibility of bioactive compounds. In this study, the astaxanthin nanoparticles with reactive oxygen species (ROS) and pH dual-response function were design and constructed using poly (propylene sulfide) covalently modified sodium alginate as carriers based on ultrasonic assisted self-assembly strategy. Atomic force microscope and scanning electron microscope analysis showed that the nanoparticles were spherical in shape with a size of around 260 nm. Meanwhile, the astaxanthin nanoparticles showed both pH and ROS stimuli-responsive release characteristics. In vitro cell experiments showed that astaxanthin nanoparticles significantly inhibited the production of ROS and mitochondrial depolarization induced by oxidative stress. In vivo colitis experiment of mice revealed that astaxanthin nanoparticles could significantly relieve colitis, protect the integrity of colon tissue and restore the expression of tight junction proteins ZO-1 and occludin. The abundance of Lactobacillus and Lachnospiraceae, and the ratio of Firmicutes/Bacteroidota of gut microbiota were significantly improved after intervention of the stimuli-responsive astaxanthin nanoparticles. This work provided a simple strategy for constructing ROS/pH dual response delivery system, which provided an experimental basis for improving the oral bioavailability of hydrophobic active compounds.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced Drug Delivery Systems · Advanced Nanomaterials in Catalysis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (60)

Show source-provided references
1. Oral delivery of folate-targeted resveratrol-loaded nanoparticles for inflammatory bowel disease therapy in rats10.1016/j.lfs.2020.118555 ↗
2. Colitis-targeted hybrid nanoparticles-in-microparticles system for the treatment of ulcerative colitis10.1016/j.actbio.2020.09.017 ↗
3. Self-assembly of zein-based microcarrier system for colon-targeted oral drug delivery10.1021/acs.iecr.8b02092 ↗
4. Therapeutic nanoparticles from grape seed for modulating oxidative stress10.1002/smll.202102485 ↗
5. An efficient enzyme-triggered controlled release system for colon-targeted oral delivery to combat dextran sodium sulfate (DSS)-induced colitis in mice10.1080/10717544.2021.1934189 ↗
6. Redox-sensitive nanoparticles based on 4-aminothiophenol-carboxymethyl inulin conjugate for budesonide delivery in inflammatory bowel diseases10.1016/j.carbpol.2017.12.021 ↗
7. An orally administered redox nanoparticle that accumulates in the colonic mucosa and reduces colitis in mice10.1053/j.gastro.2012.06.043 ↗
8. Size-dependent bioadhesion of micro- and nanoparticulate carriers to the inflamed colonic mucosa10.1023/A:1011032328064 ↗
9. Nanozyme-mediated catalytic nanotherapy for inflammatory bowel disease10.7150/thno.33727 ↗
10. pH-Responsive alginate-based microparticles for colon-targeted delivery of pure cyclosporine a crystals to treat ulcerative colitis10.3390/pharmaceutics13091412 ↗
11. A superoxide dismutase/catalase mimetic nanomedicine for targeted therapy of inflammatory bowel disease10.1016/j.biomaterials.2016.08.010 ↗
12. A proresolving peptide nanotherapy for site-specific treatment of inflammatory bowel disease by regulating proinflammatory microenvironment and gut microbiota10.1002/advs.201900610 ↗
13. Photo-triggered self-destructive ROS-responsive nanoparticles of high paclitaxel/chlorin e6 co-loading capacity for synergetic chemo-photodynamic therapy10.1016/j.jconrel.2020.04.027 ↗
14. Drug-free ROS sponge polymeric microspheres reduce tissue damage from ischemic and mechanical injury10.1021/acsbiomaterials.6b00804 ↗
15. Ginsenoside Rg3-loaded, reactive oxygen species-responsive polymeric nanoparticles for alleviating myocardial ischemia-reperfusion injury10.1016/j.jconrel.2019.11.032 ↗
16. Reactive oxygen species-responsive polymeric nanoparticles for alleviating sepsis-induced acute liver injury in mice10.1016/j.biomaterials.2017.08.008 ↗
17. Astaxanthin: a mechanistic review on its biological activities and health benefits10.1016/j.phrs.2018.08.012 ↗
18. Astaxanthin protects mesangial cells from hyperglycemia-induced oxidative signaling10.1002/jcb.21583 ↗
19. Extensive bioactivity of astaxanthin from Haematococcus pluvialis in human10.1007/978-981-15-7360-6_23 ↗
20. Astaxanthin-shifted gut microbiota is associated with inflammation and metabolic homeostasis in mice10.1093/jn/nxaa222 ↗
21. Astaxanthin, a xanthophyll carotenoid, prevents development of dextran sulphate sodium-induced murine colitis10.3164/jcbn.18-47 ↗
22. Astaxanthin inhibits tumor invasion by decreasing extracellular matrix production and induces apoptosis in experimental rat colon carcinogenesis by modulating the expressions of ERK-2, NFkB and COX-210.1007/s10637-009-9342-5 ↗
23. Preparation of astaxanthin-loaded liposomes: characterization, storage stability and antioxidant activity10.1080/19476337.2018.1437080 ↗
24. The delivery of sensitive food bioactive ingredients: absorption mechanisms, influencing factors, encapsulation techniques and evaluation models10.1016/j.foodres.2019.02.024 ↗
25. Preparation of astaxanthin-encapsulated complex with zein and oligochitosan and its application in food processing10.1016/j.lwt.2019.02.055 ↗
26. Solid lipid-polymer hybrid nanoparticles by in situ conjugation for oral delivery of astaxanthin10.1021/acs.jafc.8b02827 ↗
27. Ultrasonic self-emulsification nanocarriers for cellular enhanced astaxanthin delivery10.1021/acs.jafc.0c05983 ↗
28. A smart cauliflower-like carrier for astaxanthin delivery to relieve colon inflammation10.1016/j.jconrel.2022.01.014 ↗
29. Alginate/chitosan microparticles for gastric passage and intestinal release of therapeutic protein nanoparticles10.1016/j.jconrel.2018.12.017 ↗
30. Structure and spectroscopic studies of homo-and heterometallic complexes of adipic acid dihydrazide10.1016/j.saa.2014.01.071 ↗
31. Shear stress and ROS-responsive biomimetic micelles for atherosclerosis via ROS consumption10.1016/j.msec.2021.112164 ↗
32. Isolation and FTIR-ATR and 1H NMR characterization of alginates from the main alginophyte species of the atlantic coast of Morocco10.3390/molecules25184335 ↗
33. Effect of lipopolysaccharide (LPS) stimulation on apoptotic process and oxidative stress in fibroblast cell of hybrid crucian carp compared with those of Carassius cuvieri and Carassius auratus red var10.1016/j.cbpc.2021.109085 ↗
34. Protective effect of biogenic polyphosphate nanoparticles from Synechococcus sp. PCC 7002 on dextran sodium sulphate-induced colitis in mice10.1039/C8FO01861H ↗
35. Curcumin nanocrystal/pH-responsive polyelectrolyte multilayer core-shell nanoparticles for inflammation-targeted alleviation of ulcerative colitis10.1021/acs.biomac.0c00589 ↗
36. Netrin-1 regulates colon-kidney cross talk through suppression of IL-6 function in a mouse model of DSS-colitis10.1152/ajprenal.00702.2012 ↗
37. 6-Gingerol improves testicular function in mice model of chronic ulcerative colitis10.1177/0960327117703689 ↗
38. Effect of astaxanthin nanoparticles in protecting the post-thawing quality of rooster sperm challenged by cadmium administration10.1016/j.psj.2019.12.006 ↗
39. Hyaluronic acid-bilirubin nanomedicine for targeted modulation of dysregulated intestinal barrier, microbiome and immune responses in colitis10.1038/s41563-019-0462-9 ↗
40. Calcium pectinate and hyaluronic acid modified lactoferrin nanoparticles loaded rhein with dual-targeting for ulcerative colitis treatment10.1016/j.carbpol.2021.117998 ↗
41. Gut microbiota regulation and anti-inflammatory effect of beta-carotene in dextran sulfate sodium-stimulated ulcerative colitis in rats10.1111/1750-3841.15684 ↗
42. The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment10.1093/carcin/bgp014 ↗
43. Caffeic acid supplement alleviates colonic inflammation and oxidative stress potentially through improved gut microbiota community in mice10.3389/fmicb.2021.784211 ↗
44. Naringin exhibited therapeutic effects against DSS-induced mice ulcerative colitis in intestinal barrier-dependent manner10.3390/molecules26216604 ↗
45. Green pea (Pisum sativum L.) hull polyphenol extracts ameliorate DSS-induced colitis through Keap1/Nrf2 pathway and gut microbiota modulation10.3390/foods10112765 ↗
46. Selection strategy of dextran sulfate sodium-induced acute or chronic colitis mouse models based on gut microbial profile10.1186/s12866-021-02342-8 ↗
47. Dendrobium fimbriatum Hook polysaccharide ameliorates dextran-sodium-sulfate-induced colitis in mice via improving intestinal barrier function, modulating intestinal microbiota, and reducing oxidative stress and inflammatory responses10.1039/D1FO03003E ↗
48. Ulcerative colitis relapse after Helicobacter pylori eradication in a 12-year-old boy with duodenal ulcer10.1186/s12876-021-02010-1 ↗
49. Gut microbiota-dependent catabolites of tryptophan play a predominant role in the protective effects of turmeric polysaccharides against DSS-induced ulcerative colitis10.1039/D1FO01468D ↗
50. Dextran sulfate sodium salt-induced colitis aggravates gut microbiota dysbiosis and liver injury in mice with non-alcoholic steatohepatitis10.3389/fmicb.2021.756299 ↗
51. The underlying mechanism of A-type procyanidins from peanut skin on DSS-induced ulcerative colitis mice by regulating gut microbiota and metabolism10.1111/jfbc.14103 ↗
52. Polysaccharide from Scutellaria barbata D. Don attenuates inflammatory response and microbial dysbiosis in ulcerative colitis mice10.1016/j.ijbiomac.2022.02.119 ↗
53. Physiologically inspired mucin coated escherichia coli nissle 1917 enhances biotherapy by regulating the pathological microenvironment to improve intestinal colonization10.1021/acsnano.1c09681 ↗
54. Intake of high-purity insoluble dietary fiber from Okara for the amelioration of colonic environment disturbance caused by acute ulcerative colitis10.1039/D1FO02264D ↗
55. Melatonin mitigates oxazolone-induced colitis in microbiota-dependent manner
56. Effects of probiotics and prebiotics on intestinal microbiota in mice with acute colitis based on 16S rRNA gene sequencing10.1097/CM9.0000000000000308 ↗
57. Bionic regulators break the ecological niche of pathogenic bacteria for modulating dysregulated microbiome in colitis10.1002/adma.202204650 ↗
58. Hydroxytyrosol alleviates dextran sulfate sodium-induced colitis by modulating inflammatory responses, intestinal barrier, and microbiome10.1021/acs.jafc.1c07568 ↗
59. Metformin exerts anti-inflammatory and mucus barrier protective effects by enriching akkermansia muciniphila in mice with ulcerative colitis10.3389/fphar.2021.726707 ↗
60. Diving into Inflammation: a pilot study exploring the dynamics of the immune-microbiota axis in ileal tissue layers of patients with crohn's disease10.1093/ecco-jcc/jjab034 ↗